Ginkgo Bioworks Holdings, Inc. cotiza a 11.79 USD y tiene una capitalización bursátil de $794M. En los últimos 12 meses ha facturado $112M con un margen de flujo de caja libre del -105.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functiona…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.73 | $-1.39 | $-0.77 |
| Estimado | $-0.58 | $-0.70 | $-1.34 | $-1.11 |
| Sorpresa | — | -4.3% | -3.7% | +30.6% |
| Métrica | DNA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -185.3% | -38.6% | -146.7% |
| Net Margin | -183.8% | -33.6% | -150.3% |
| FCF Margin | -105.0% | -13.9% | -91.2% |
| ROE | -61.5% | -40.4% | -21.1% |
| ROA | -27.9% | -32.0% | +4.1% |
| Current Ratio | 4.92 | 2.84 | +2.08 |
| Debt / Equity | — | 0.28 | — |